Adverse events reported to the Food and Drug Administration from 2004 to 2016 for cosmetics and personal care products marketed to newborns and infants

被引:9
|
作者
Cornell, Erika [1 ]
Kwa, Michael [1 ]
Paller, Amy S. [2 ]
Xu, Shuai [2 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL 60611 USA
关键词
adverse events; allergic contact dermatitis; cosmetics; Food and Drug Administration; personal care products; regulation; PERINEAL DERMATITIS;
D O I
10.1111/pde.13419
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background/ObjectivesDespite their ubiquitous use and several recent health controversies involving cosmetics and personal care products for children, the Food and Drug Administration has little oversight of these products and relies on consumer-submitted adverse event reports. We assessed the recently released Center for Food Safety and Applied Nutrition's Adverse Event Reporting System database for adverse event reports submitted to the Food and Drug Administration for baby personal care products and to determine whether useful insights can be derived. MethodsWe extracted the Center for Food Safety and Applied Nutrition's Adverse Event Reporting System data file from 2004 to 2016 and examined the subset classified according to the Food and Drug Administration-designated product class as a baby product. Events were manually categorized into product type and symptom type to assess for trends. ResultsOnly 166 total adverse events were reported to the Food and Drug Administration for baby products from 2004 to 2016. The majority of reports indicated rash or other skin reaction; 46% of reported events led to a health care visit. ConclusionPediatric dermatologists should consider submitting cosmetics and personal care product adverse event reports and encouraging consumers to do so likewise insituations in which a product adversely affects a child's health.
引用
收藏
页码:225 / 229
页数:5
相关论文
共 50 条
  • [41] Unusual distributions of body fat in AIDS patients: A review of adverse events reported to the Food and Drug Administration
    Mann, M
    Piazza-Hepp, T
    Koller, E
    Struble, K
    Murray, J
    AIDS PATIENT CARE AND STDS, 1999, 13 (05) : 287 - 295
  • [42] Adverse events associated with budesonide nasal irrigation reported to the US Food and Drug Administration: 2007 to 2022
    Rathi, Vinay K. K.
    Sawicki, Nicholas W. W.
    Schlosser, Rodney J. J.
    Soler, Zachary M. M.
    Scangas, George A. A.
    Workman, Alan D. D.
    Gray, Stacey T. T.
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2024, 14 (01) : 123 - 126
  • [43] CAR T-Cell Therapy Associated Ocular Adverse Events Reported to the Food and Drug Administration
    Fischer, Andrew
    Li, Albert
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [44] Retrospective analysis of adverse events with topical onychomycosis medications reported to the United States Food and Drug Administration
    Wang, Yu
    Lipner, Shari R.
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2020, 312 (08) : 581 - 586
  • [45] Examining the Nocebo Effect of Statins Through Statin Adverse Events Reported in the Food and Drug Administration Adverse Event Reporting System
    Moon, Jungyeon
    Sedgh, Robert Cohen
    Jackevicius, Cynthia A.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2021, 14 (01): : 28 - 37
  • [46] Botulinum toxin type A injections:: Adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases
    Coté, TR
    Mohan, AK
    Polder, JA
    Walton, MK
    Braun, MM
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 53 (03) : 407 - 415
  • [47] Cardiovascular toxicities with pediatric tyrosine kinase inhibitor therapy: An analysis of adverse events reported to the Food and Drug Administration
    Narayan, Hari K.
    Sheline, Karyn
    Wong, Victor
    Kuo, Dennis
    Choo, Sun
    Yoon, Janet
    Leger, Kasey
    Kutty, Shelby
    Fradley, Michael
    Tremoulet, Adriana
    Ky, Bonnie
    Armenian, Saro
    Guha, Avirup
    PEDIATRIC BLOOD & CANCER, 2023, 70 (02)
  • [48] SERIOUS ADVERSE EVENTS IN NORPLANT USERS REPORTED TO THE FOOD-AND-DRUG-ADMINISTRATION MEDWATCH SPONTANEOUS REPORTING SYSTEM
    SIVIN, I
    OBSTETRICS AND GYNECOLOGY, 1995, 86 (02): : 318 - 319
  • [49] Robotic Urologic Surgery: Trends in Food and Drug Administration-Reported Adverse Events Over the Last Decade
    Nik-Ahd, Farnoosh
    Souders, Colby P.
    Houman, Justin
    Zhao, Hanson
    Chughtai, Bilal
    Anger, Jennifer T.
    JOURNAL OF ENDOUROLOGY, 2019, 33 (08) : 649 - 654
  • [50] A summary of Food and Drug Administration-reported adverse events and drug interactions occurring during therapy with omeprazole, lansoprazole and pantoprazole
    Labenz, J
    Petersen, KU
    Rösch, W
    Koelz, HR
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (08) : 1015 - 1019